Exome and Genome Sequencing and Parallels in Radiology: Searching for Patient-Centered Management of Incidental and Secondary Findings

被引:5
|
作者
Kang, Stella K. [1 ,2 ]
Spector-Bagdady, Kayte [3 ]
Caplan, Arthur L. [4 ]
Braithwaite, R. Scott [2 ,5 ]
机构
[1] NYU, Sch Med, Dept Radiol, New York, NY USA
[2] NYU, Sch Med, Dept Populat Hlth, New York, NY USA
[3] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI USA
[4] NYU, Dept Populat Hlth, Div Med Eth, Sch Med, New York, NY USA
[5] NYU, Sch Med, Dept Med, New York, NY USA
关键词
Incidental finding; genome sequencing; patient-centered care; WHITE PAPER; COMMITTEE II; PELVIC CT; AUTONOMY; RETURN; MRI;
D O I
10.1016/j.jacr.2016.06.050
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Incidental and secondary findings have become an important by-product of diagnostic testing, and their ramifications affect clinical care, research, and policy. Given parallels in the reporting and management of such findings on diagnostic imaging, radiologists may draw from ongoing discussions in medical genetics to rethink more patient-centered approaches to analogous clinical, ethical, and medicolegal dilemmas. Low-risk incidental findings in particular may be drivers of unnecessary testing, invasive procedures, and overtreatment, with associated financial, psychological, and clinical consequences. As radiologists act in patients' best interests by strengthening standardized guidelines on how each finding merits further diagnostic testing or treatment, perhaps the greatest challenge for producing such guidelines is for low-risk incidental findings, for which adverse consequences are unlikely but associated with substantial uncertainty because of the lack of strong evidence on which to base the recommendations. More uniform recommendations for managing low-risk radiologic incidental findings should therefore aim to provide reasonable options that apply across a spectrum of patient preferences. These will require evaluation through research and will ultimately influence the quality of care. Specific areas for exploration may include (1) better gauging of patient attitudes and preferences regarding low-risk incidental findings, (2) using patient preferences to inform more uniform recommendations for low-risk findings that apply across a spectrum of preferences and help guide shared decision making, and (3) when patients endorse a strong preference not to discover low-risk incidental findings, how it might be possible for professional standards to curtail their generation in specific circumstances.
引用
收藏
页码:1467 / 1472
页数:6
相关论文
共 43 条
  • [21] Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders
    Carrasco, Estela
    Lopez-Fernandez, Adria
    Codina-Sola, Marta
    Valenzuela, Irene
    Cueto-Gonzalez, Am
    Villacampa, Guillermo
    Navarro, Victor
    Torres-Esquius, Sara
    Palau, Dolors
    Cruellas, Mara
    Torres, Maite
    Perez-Duenas, Belen
    Abuli, Anna
    Diez, Orland
    Sabado-Alvarez, Constantino
    Garcia-Arumi, Elena
    Tizzano, Eduardo F.
    Moreno, Lucas
    Balmana, Judith
    JOURNAL OF MEDICAL GENETICS, 2023, 60 (07) : 685 - 691
  • [22] A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
    Berg, Jonathan S.
    Foreman, Ann Katherine M.
    O'Daniel, Julianne M.
    Booker, Jessica K.
    Boshe, Lacey
    Carey, Timothy
    Crooks, Kristy R.
    Jensen, Brian C.
    Juengst, Eric T.
    Lee, Kristy
    Nelson, Daniel K.
    Powell, Bradford C.
    Powell, Cynthia M.
    Roche, Myra I.
    Skrzynia, Cecile
    Strande, Natasha T.
    Weck, Karen E.
    Wilhelmsen, Kirk C.
    Evans, James P.
    GENETICS IN MEDICINE, 2016, 18 (05) : 467 - 475
  • [23] Mandatory Extended Searches in All Genome Sequencing "Incidental Findings," Patient Autonomy, and Shared Decision Making
    Ross, Lainie Friedman
    Rothstein, Mark A.
    Clayton, Ellen Wright
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (04): : 367 - 368
  • [24] Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature
    Delanne, J.
    Nambot, S.
    Chassagne, A.
    Putois, O.
    Pelissier, A.
    Peyron, C.
    Gautier, E.
    Thevenon, J.
    Cretin, E.
    Bruel, A. L.
    Goussot, V.
    Ghiringhelli, F.
    Boidot, R.
    Mau-Them, F. Tran
    Philippe, C.
    Vitobello, A.
    Demougeot, L.
    Vernin, C.
    Lapointe, A. S.
    Bardou, M.
    Luu, M.
    Binquet, C.
    Lejeune, C.
    Joly, L.
    Juif, C.
    Baurand, A.
    Sawka, C.
    Bertolone, G.
    Duffourd, Y.
    Sanlaville, D.
    Pujol, P.
    Genevieve, D.
    Houdayer, F.
    Thauvin-Robinet, C.
    Faivre, L.
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2019, 62 (06)
  • [25] Comparison between the attitudes of genetics professionals and patients towards incidental findings from whole-genome or whole-exome sequencing
    Aloraini, T. M.
    Gari, A.
    AlKarbani, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 674 - 674
  • [26] Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing
    Shahmirzadi, Layla
    Chao, Elizabeth C.
    Palmaer, Erika
    Parra, Melissa C.
    Tang, Sha
    Gonzalez, Kelly D. Farwell
    GENETICS IN MEDICINE, 2014, 16 (05) : 395 - 399
  • [27] INCIDENTAL FINDINGS BY TARGETED EXOME SEQUENCING USED TO DIAGNOSE RARE INHERITED BLEEDING DISORDERS-PATIENT'S CHOICES ON INFORMATION AND OUTCOME
    Leinoe, E. B.
    Rossing, M.
    Ostrup, O.
    Kampmann, P.
    Andersson, N. G.
    Zetterberg, E.
    HAEMATOLOGICA, 2016, 101 : 406 - 406
  • [28] Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
    Mackley, Michael P.
    Fletcher, Benjamin
    Parker, Michael
    Watkins, Hugh
    Ormondroyd, Elizabeth
    GENETICS IN MEDICINE, 2017, 19 (03) : 283 - 293
  • [29] Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Gordon, Adam S.
    Amendola, Laura M.
    Adelman, Kathy
    Bale, Sherri J.
    Chung, Wendy K.
    Gollob, Michael H.
    Harrison, Steven M.
    Herman, Gail E.
    Hershberger, Ray E.
    Klein, Teri E.
    McKelvey, Kent
    Richards, C. Sue
    Vlangos, Christopher N.
    Stewart, Douglas R.
    Watson, Michael S.
    Martin, Christa Lese
    GENETICS IN MEDICINE, 2021, 23 (08) : 1391 - 1398
  • [30] Taking a proactive role in patient management of important incidental imaging findings: How can we increase the "value' of diagnostic radiology service and improve quality of patient care?
    Hayashi, Daichi
    Guermazi, Ali
    JAPANESE JOURNAL OF RADIOLOGY, 2018, 36 (10) : 579 - 580